Skip to content

RNTX RNTX Cash ratio

Cash ratio at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
0.5×0.0×
Gilead Sciences logo
Gilead SciencesGILD
0.8×+0.2×
AbbVie logo
AbbVieABBV
0.2×+0.1×
CTO
Citius Oncology, Inc.CTOR
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
0.9×-0.1×
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
1.9×+1.1×

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+164%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×
Current ratio0.4×-1.0×

Where this comes from

Calculated from RNTX’s reported figures.

Based on the most recent quarter.

The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's cash ratio?
RNTX (RNTX) reported cash ratio of 0.3× in Q1 2026.
How has RNTX's cash ratio changed year-over-year?
RNTX's cash ratio decreased by 73.8% year-over-year, from 1.2× to 0.3×.
What is the long-term trend for RNTX's cash ratio?
Over 5 years (2020 to 2025), RNTX's cash ratio has grown at a -21.8% compound annual growth rate (CAGR), from 1.8× to 0.5×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.